Clinical trial
Study of DF6215 in Patients With Advanced Solid Tumors
NCT06108479
Study timeline
Study start (actual)2023-11-28Date precision: day
Registry last updated2026-03-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Solid Tumor, Adultunresolved
Solid Tumor Cancerunresolved
Interventions
Sponsors & collaborators
Dragonfly Therapeuticslead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
TampaFlorida, United States2MarseilleFrance2BordeauxFrance2New YorkNew York, United States1Los AngelesCalifornia, United States1NashvilleTennessee, United States1ParisFrance1San DiegoCalifornia, United States1ToulouseFrance1ProvidenceRhode Island, United States1OrangeCalifornia, United States1DijonFrance1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06108479 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.